Injective ETF Secures Nasdaq Listing Approval Under INJC Ticker

Key Insights: Injective ETF receives Nasdaq listing approval under INJC; trading awaits an effective S-1. Canary Capital plans to stake at least 90% of INJ holdings, with BitGo providing custody. The INJ price was reported near $7.64, with $7.30 support and 8.00–8.20 targets in focus. Canary Capital has secured Nasdaq listing approval for its Staked Injective ETF, according to a November 3 SEC filing . The fund plans to trade under INJC, although public sales must wait until its S-1 registration becomes effective. Under normal circumstances, its strategy includes staking at least 90% of its INJ holdings, with BitGo providing custody. The development comes as INJ attempts to recover above $7.30. Buyers also face resistance near $7.92.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to The Coin Republic.